Related Experiment Videos
[Immunomodulator structure-activity relationships: contribution of molecular modeling]
J J Panouse1, H Giorgi, J Daspet
1Equipe de Chimie thérapeutique et Laboratoire de Biophysique médicale et pharmaceutique, Faculté de Médecine et de Pharmacie, 4, place St-Jacques, F. 25000, Besançon.
Annales Pharmaceutiques Francaises
|November 4, 2000
Summary
Molecular modeling revealed a common pharmacophore in immunostimulant and immunosuppressive compounds. This shared structure, featuring four specific atoms, aids in understanding immunomodulator mechanisms and designing new drugs.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Immunology
Context:
- Immunomodulator drugs, including immunostimulants and immunosuppressants, are crucial for treating various diseases.
- Understanding their molecular mechanisms is key to developing more effective therapies.
Purpose:
- To identify common structural features and pharmacophores across diverse immunomodulator compounds using molecular modeling.
- To elucidate the mechanism of action for immunostimulants and immunosuppressants.
Summary:
- Molecular modeling of 64 immunostimulant compounds with pyrrolie quinolein or purine nuclei identified a common spatial structure in active molecules.
- A shared pharmacophore, comprising three adjacent electroattractive atoms and a fourth atom, was found in all studied immunostimulants (e.g., levamisole, muramyldipeptide) and immunosuppressants (e.g., rapamycin).
- The non-stable, yet active, conformation of rapamycin may explain activity loss in modified macrolides.
Impact:
- Validates a novel concept for immunomodulator drug design.
- Provides insights into the mechanism of action for a broad range of immunomodulator compounds.
- Facilitates the rational design of novel immunomodulatory therapeutics.